Partner to Keep Our Patients Safe and Well Next Winter

Concepts

• cardiff
• information technology
• safe
• next winter
• well
• patients
• next
• winter
• keep
• velindre nhs trust

Location

Cardiff

Description

NHS Wales Shared Services Partnership, on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a primary three year contract with option to extend for up to a further twenty four months for a Partner to Keep Our Patients Safe and Well Next Winter.

Ammendments to Previous Notice

Award Detail

CPV Codes

• 72222300 - Information technology services

Indicators

• Contract modified due to additional needs.

Legal Justification

The Health Board are anticipating that they will be self sufficient following the end of the 12 months extension. Based on this, re-procurement for the next 12 months would cause substantial cost both in terms of monetary value and staff resource as there would need to be considerable technical resource deployed if another company could indeed provide an immediate comparable platform alternative alongside high training considerations.

Other Information

Lightfoot has become the Health Board’s partner in developing and supporting scaling change through the use of data in a single exclusive platform which provides a unique offering which is detailed as follows; 1. Lightfoot has extensive technical experience in linking together health system datasets from many different sources to provide a timeseries flow view of the patient journey through the whole health system. This automatically refreshes daily for operational use and would take most organisations many months/years to build this facility/capability. 2. Unique Statistical Process Control (SPC) insights from signalsfromnoise (sfn): a. The SPC visualisation of data is different from traditional reporting tools and is the only operational enterprise-wide platform automatically generating and distributing SPC charts and visualised views of cross system patient journeys. b. The charts have a unique capability, in that they can provide trended and cyclical views of data which also include predictive analytics. c. This allows SPC views of patient flow across departments, organisations and multiple organisations, in one single environment, with a live drill down capability to answer any questions across all of the data sets. This is patented in North America and applied for in Europe. 3. Common analytical platform to Canterbury District Health Board: The HB have developed a learning alliance with Canterbury DHB NZ using Lightfoot’s sfn system, enabling comparison analytics between the different systems, departments, patient journeys and clinical cohorts to inform best practice and opportunities for improvement. 4. Live drilldown and clinical challenge: During playback workshops sfn’s instant drilldown capability allows clinicians to ask and answer live “why” questions without the need for further report writing. 5. Live initiative monitoring: The sfn platform is updated with frequent uploads of data allowing it to become the HB’s initiative, monitoring and tracking tool. 6. Outcomes and Quality and Safety Frameworks: The sfn platform provides the option to link to a Canterbury-style outcomes framework in order to connect the HB’s strategic vision to patient outcomes. The recent delivery workstreams have enabled the HB to test and experience in a live operational application sfn and the implementation methodology, and would now like to take this wider than the initial work. Due to this requirement and the uniqueness of the platform, a three to five year partnership is necessary to give the Health Board the time to continue to develop and embed the approach, grow the capability and capacity, so that we can sustain this in the long term. In addition, there are a number of implications on the Health Board in regards to time, resource and finances if a contract could not be agreed with Lightfoot, these are; 1. Lightfoot’s system and data is their intellectual property and as such, this would not be transferable. 2. The organisation implication in the reinvestment of HB resources to implement this live system again would be highly significant and detrimental to clinical time and would seriously impact the project progress. 3. Financial investment by the HB has been agreed, however, costs would significantly increase if implementation had to be re-engineered. (WA Ref:142936)